Elektrofi
Latest round
- Series C
Last raised
- Aug 2024
Total raised
- $155M
Investors
- 20
About Elektrofi
Founded in 2016 and based in Massachusetts, US, Elektrofi, Inc. operates as a biotechnology company that develops a range of biologic therapies through a formulation platform that utilizes proprietary microparticle technology for monoclonal antibodies, therapeutic proteins, and other large molecule drugs. In October 2024, Elektrofi, Inc. Elektrofi's offers a proprietary microparticle technology platform that enables patient-friendly small-volume subcutaneous injections for monoclonal antibodies, therapeutic proteins, and other large-molecule drugs which are more convenient than intravenous infusions. The company's products include prefilled syringes, pen injectors, and autoinjectors. Elektrofi's partners include LEO, Sanofi, NSF, and NIIMBL. The company plans to use a portion of the Series B proceeds to establish a centralized GMP manufacturing line in support of multiple clinical trials. It also plans to double employee headcount over the next 12-18 months to accelerate development across a pipeline of licensed programs. In October 2025, Halozyme, Inc.’s drug delivery technology portfolio by integrating a microparticle formulation platform for high-concentration biologics.
Who invested in Elektrofi
20 investors across 2 rounds
See all investors in Elektrofi
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elektrofi
Who invested in Elektrofi?
Elektrofi has 20 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elektrofi raised?
Elektrofi has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Elektrofi last raise money?
Elektrofi's most recent round on record is a Series C, in Aug 2024.
What does Elektrofi do?
Founded in 2016 and based in Massachusetts, US, Elektrofi, Inc.
Where is Elektrofi headquartered?
Elektrofi is headquartered in Boston, US.
Which VCs invest in companies like Elektrofi?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elektrofi's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Elektrofi? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.